145 related articles for article (PubMed ID: 17457305)
1. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.
Zhang Y; Forootan SS; Liu D; Barraclough R; Foster CS; Rudland PS; Ke Y
Prostate Cancer Prostatic Dis; 2007; 10(3):293-300. PubMed ID: 17457305
[TBL] [Abstract][Full Text] [Related]
2. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.
Forootan SS; Wong YC; Dodson A; Wang X; Lin K; Smith PH; Foster CS; Ke Y
Hum Pathol; 2007 Sep; 38(9):1321-9. PubMed ID: 17599389
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of osteopontin expression in human prostate cancer.
Forootan SS; Foster CS; Aachi VR; Adamson J; Smith PH; Lin K; Ke Y
Int J Cancer; 2006 May; 118(9):2255-61. PubMed ID: 16331611
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of anterior gradient gene AGR2 in prostate cancer.
Maresh EL; Mah V; Alavi M; Horvath S; Bagryanova L; Liebeskind ES; Knutzen LA; Zhou Y; Chia D; Liu AY; Goodglick L
BMC Cancer; 2010 Dec; 10():680. PubMed ID: 21144054
[TBL] [Abstract][Full Text] [Related]
5. Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.
Kani K; Malihi PD; Jiang Y; Wang H; Wang Y; Ruderman DL; Agus DB; Mallick P; Gross ME
Prostate; 2013 Feb; 73(3):306-15. PubMed ID: 22911164
[TBL] [Abstract][Full Text] [Related]
6. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
[TBL] [Abstract][Full Text] [Related]
7. The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.
Al Fayi MS; Gou X; Forootan SS; Al-Jameel W; Bao Z; Rudland PR; Cornford PA; Hussain SA; Ke Y
Oncotarget; 2016 Dec; 7(50):82783-82797. PubMed ID: 27779102
[TBL] [Abstract][Full Text] [Related]
8. Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas.
Riener MO; Thiesler T; Hellerbrand C; Amann T; Cathomas G; Fritzsche FR; Dahl E; Bahra M; Weichert W; Terracciano L; Kristiansen G
Eur J Cancer; 2014 Jul; 50(10):1722-1730. PubMed ID: 24794000
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cell phenotypes based on AGR2 and CD10 expression.
Ho ME; Quek SI; True LD; Morrissey C; Corey E; Vessella RL; Dumpit R; Nelson PS; Maresh EL; Mah V; Alavi M; Kim SR; Bagryanova L; Horvath S; Chia D; Goodglick L; Liu AY
Mod Pathol; 2013 Jun; 26(6):849-59. PubMed ID: 23348903
[TBL] [Abstract][Full Text] [Related]
10. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C
Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467
[TBL] [Abstract][Full Text] [Related]
11. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
[TBL] [Abstract][Full Text] [Related]
12. Ribosomal protein l19 is a prognostic marker for human prostate cancer.
Bee A; Ke Y; Forootan S; Lin K; Beesley C; Forrest SE; Foster CS
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2061-5. PubMed ID: 16609016
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.
Callen DF; Ricciardelli C; Butler M; Stapleton A; Stahl J; Kench JG; Horsfall DJ; Tilley WD; Schulz R; Nesland JM; Neilsen PM; Kumar R; Holm R
Oncol Rep; 2010 Apr; 23(4):1045-52. PubMed ID: 20204290
[TBL] [Abstract][Full Text] [Related]
14. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW
Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076
[TBL] [Abstract][Full Text] [Related]
15. PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy.
Kao KR; Popadiuk P; Thoms J; Aoki S; Anwar S; Fitzgerald E; Andrews P; Voisey K; Gai L; Challa S; He Z; Gonzales-Aguirre P; Simmonds A; Popadiuk C
J Clin Pathol; 2018 May; 71(5):402-411. PubMed ID: 28924059
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study.
Wambach M; Montani M; Runz J; Stephan C; Jung K; Moch H; Eberli D; Bernhardt M; Hommerding O; Kreft T; Cronauer MV; Kremer A; Mayr T; Hauser S; Kristiansen G
APMIS; 2024 Apr; 132(4):256-266. PubMed ID: 38288749
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract][Full Text] [Related]
18. Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.
Neeb A; Hefele S; Bormann S; Parson W; Adams F; Wolf P; Miernik A; Schoenthaler M; Kroenig M; Wilhelm K; Schultze-Seemann W; Nestel S; Schaefer G; Bu H; Klocker H; Nazarenko I; Cato AC
Oncotarget; 2014 Sep; 5(18):8681-9. PubMed ID: 25237833
[TBL] [Abstract][Full Text] [Related]
19. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Yamano S; Komatsu H; Hanada S; Wei M; Wanibuchi H; Suehiro S; Kakehashi A
Cancer Biomark; 2011-2012; 10(2):101-7. PubMed ID: 22430137
[TBL] [Abstract][Full Text] [Related]
20. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
